The exchange of Fe(3+), Tb(3+), In(3+), Ga(3+), and Al(3+) between the C-terminal metal-binding site of the serum iron transport protein transferrin and the low-molecular-mass serum chelating agent citrate has been studied at pH 7.4 and 25 degrees C. The removal of Ga(3+), In(3+), and Al(3+) follows simple saturation kinetics with respect to the citrate concentration. In contrast, removal of both Fe(3+) and Tb(3+) shows a combination of saturation and first-order kinetic behavior with respect to the citrate concentration. The saturation component is consistent with a mechanism for metal release in which access to the bound metal is controlled by a rate-limiting conformational change in the protein. The first-order kinetic pathway is very rapid for Tb(3+), and this is attributed to a direct attack of the citrate on the Tb(3+) ion within the closed protein conformation. It is suggested that this pathway is more readily available for Tb(3+) because of the larger coordination number for this cation and the presence of an aquated coordination site in the Tb(3+)-CO(3)-Tf ternary complex. There is relatively little variation in the k(max) values for the saturation pathway for Tb(3+), Ga(3+), Al(3+), and In(3+), but the k(max) value for Fe(3+) is significantly smaller. It is suggested that protein interactions across the interdomain cleft of transferrin largely control the release of the first group of metal ions, while the breaking of stronger metal-protein bonds slows the rate of iron release. The rates of metal binding to apotransferrin are clearly controlled in large part by the hydrolytic tendencies of the free metal ions. For the more amphoteric metal ions Al(3+) and Ga(3+), there is rapid protein binding, and the addition of citrate actually retards this reaction. In contrast, the nonamphoteric In(3+) ion binds very slowly in the absence of citrate, presumably due to the rapid formation of polymeric In-hydroxo complexes upon addition of the unchelated metal ion to the pH 7.4 protein solution. The addition of citrate to the reaction accelerates the binding of In(3+) to apoTf, presumably by forming soluble, mononuclear In-citrate complexes.
Rate constants for the removal of iron from N-terminal monoferric transferrin have been measured for a series of phosphate and phosphonocarboxylic acids in pH 7.4 0.1 M hepes buffer at 25 degrees C. The bidentate ligands pyrophosphate and phosphonoacetic acid (PAA) show a combination of saturation and first-order kinetics with respect to the ligand concentration. Similar results are observed following a single substitution at the 2-position of PAA to give 2-benzyl-PAA and phosphonosuccinic acid. In contrast, disubstitution at the 2-position to form 2,2-dibenzyl-PAA leads to a marked reduction in iron removal via the first-order pathway. Rate constants were also measured for tripolyphosphate and phosphonodiacetic acid, which are elongated versions of PP(i) and PAA. In both cases, this elongation completely eliminates the first-order component for iron release while having relatively little impact on the saturation pathway. The sensitivity of the first-order component to the structure of the ligand strongly indicates that this pathway involves the binding of the ligand to a specific site on the protein and cannot be attributed to changes in the overall ionic strength of the solution as the ligand concentration increases. It is proposed that this structural sensitivity reflects steric restrictions on the ability of the incoming ligand to substitute for the synergistic carbonate anion to form a relatively unstable Fe-ligand-Tf ternary intermediate, which then dissociates to FeL and apoTf.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.